NIAID | Technology Transfer

ZIKA VIRUS VACCINES

Read more about ZIKA VIRUS VACCINES

US Application 62/396,613
Filed on 2016-09-19

Modified Anthrax Toxin Protective Antigen

Read more about Modified Anthrax Toxin Protective Antigen

US Application 62/323,218
Filed on 2016-04-15

Francisella Lipids As Broad Anti-inflammatory Therapeutics and Associated Methods of Use

Read more about Francisella Lipids As Broad Anti-inflammatory Therapeutics and Associated Methods of Use

US Application 62/319,692
Filed on 2016-04-07

Multivalent Vaccines for Rabies Virus and Coronoviruses

Read more about Multivalent Vaccines for Rabies Virus and Coronoviruses

US Application 62/318,087
Filed on 2016-04-04

Bivalent Immunogenic Conjugate for Malaria and Typhoid

Read more about Bivalent Immunogenic Conjugate for Malaria and Typhoid

US Application 62/327,184
Filed on 2016-04-25

Live Attenuated Zika Virus Vaccine

Read more about Live Attenuated Zika Virus Vaccine

US Application 62/307,170
Filed on 2016-03-11

Use of CD300B Antagonists to Treat Sepsis and Septic Shock

Read more about Use of CD300B Antagonists to Treat Sepsis and Septic Shock

US Application 62/308,144
Filed on 2016-03-14

USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS

Read more about USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS

US Application 62/324,762
Filed on 2016-04-19

PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE

Read more about PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE

US Application 62/300,822
Filed on 2016-02-27

Recombinant HIV-1 Envelope Proteins and Their Use

Read more about Recombinant HIV-1 Envelope Proteins and Their Use

US Application 62/306,006
Filed on 2016-03-09

Subscribe to NIAID